Sunday 04 May, 2025 10:01 AM
Site map | Locate Us | Login
   Kotak Mahindra Bank Q4 PAT slides 14% YoY to Rs 3,552-cr    Marico Q4 PAT rises 8% YoY to Rs 343 cr    SBI Q4 PAT falls 10% YoY to Rs 18,643 crore; declares dividend of Rs 15.90/sh    Sanofi Consumer reports 20% YoY fall in Q1 PAT to Rs 50 cr    Sunteck Realty registers PAT of Rs 50 crore in Q4; EBITDA margin at 33.5%    Parag Milk Foods posts PAT of Rs 26 crore in Q4; EBITDA margin rises to 8.2%    GOCL Corp inks deal to sell 100% stake in IDL Explosives for Rs 107 crore    Aether Inds reports turnaround PAT of Rs 503 cr in Q4 FY25    NMDC iron ore production jumps 15% YoY in April'25    Eicher Motors CV sales climb 27% YoY in April'25    Godrej Agrovet Ltd leads losers in 'A' group    Alembic Pharma receives USFDA approval for Ticagrelor tablets    Ami Organics jumps after Q4 PAT soars to Rs 627 cr    Malu Paper Mills Ltd leads losers in 'B' group    Godrej Properties posts 19% YoY drop Q4 PAT; EBITDA at Rs 634 crore 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Aarti Drugs soars on share buyback proposal
22-Aug-24   11:17 Hrs IST

The announcement was made after market hours yesterday.

Aarti Drugs forms part of $6 Billion Aarti Group of Industries with robust R&D Division at Tarapur, Maharashtra Industrial Development Corporation (MIDC) in close vicinity to manufacturing locations. The company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Speciality Chemicals and produces Formulations with its whollyowned subsidiary-Pinnacle Life Science Private.

The company's consolidated net profit declined 30.5% to Rs 33.24 crore on 16% slide in net sales to Rs 555.34 crore in Q1 FY25 over Q1 FY24.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 40637548
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd